COVID-19 in patients with lung cancerJie Luo, Matthew D. Hellmann, Kathryn C. Arbour et al.|Annals of Oncology|2020Cited by 269
Spectrum of Mechanisms of Resistance to Crizotinib and Lorlatinib in <i>ROS1</i> Fusion–Positive Lung CancerJustin F. Gainor, Noura J. Choudhury, Satoshi Yoda et al.|Clinical Cancer Research|2021Cited by 137
Effect of Osimertinib and Bevacizumab on Progression-Free Survival for Patients With Metastatic <i>EGFR</i>-Mutant Lung CancersHelena A. Yu, Mark G. Kris, Adam J. Schoenfeld et al.|JAMA Oncology|2020Cited by 131
Molecular Biomarkers of Disease Outcomes and Mechanisms of Acquired Resistance to First-Line Osimertinib in Advanced EGFR-Mutant Lung CancersNoura J. Choudhury, Helena A. Yu, Antonio Marra et al.|Journal of Thoracic Oncology|2022Cited by 95
Small-molecule targeted therapies induce dependence on DNA double-strand break repair in residual tumor cellsMoiez Ali, Kris C. Wood, Min Lu et al.|Science Translational Medicine|2022Cited by 45